We defend healthcare providers, practices, and clinics against Criminal and Civil Healthcare Matters, Medicare & Medicaid Investigations, PBM audits and UPIC Recoupment Demands, DEA Inspections, Board of Pharmacy Hearings, FDA Enforcement Actions, and Compounding Cases, across all 50 states.
"Top-notch attorneys with an unparalleled scope of experience and breadth of knowledge. You will want them in your corner."
Speak directly with a former prosecutor
Defend against OptumRx, CVS Caremark, Express Scripts, Humana, and Prime audits. Recoupment reductions, network reinstatements, federal litigation when the PBM refuses resolution.
Reverse PBM termination for cause and reinstate pharmacies into the OptumRx, UnitedHealthcare, Aetna, ESI, Humana, and Prime networks. 7-NY pharmacy reinstatement anchor.
OptumRx-specific audit defense. Operational expertise from inside the network (Anthony Mahajan was Chief Compliance Officer of UnitedHealth Group, OptumRx's parent). $4.7M recoupment reduced to $180K.
Federal healthcare fraud defense across DOJ Civil and Criminal, HHS-OIG, FBI, DEA, the state Medicaid Fraud Control Units, and state licensing boards.
Qui tam relator suits, Civil Investigative Demands, and DOJ Civil Division investigations. Anchored on a Rule 9(b) particularity dismissal of an oncology FCA matter at the pleading stage.
DEA defense for pharmacies, distributors, manufacturers, and importers. Order to Show Cause proceedings and suspicious order monitoring (SOM). Led by a 32-year DEA Diversion veteran.
503A pharmacy and 503B outsourcing facility defense. FDA inspections, DQSA enforcement, GLP-1/peptide compounding, USP 797 sterility. Led by a pharmacist-attorney with 200+ FDA publications.
Umbrella for UPIC, RAC, MAC, SMRC, and CERT contractor audit defense. The 5-level Medicare appeals track from redetermination to federal court.
State Board of Pharmacy complaints, inspections, disciplinary hearings, and license defense for pharmacies and pharmacists - coordinated with any parallel PBM, DEA, or Medicaid matter.
FDA inspections, Form 483 responses, Warning Letters, and DQSA compounding enforcement for 503A pharmacies and 503B outsourcing facilities.
Patent disputes, brand-manufacturer lawsuits, and essentially-copies allegations against compounded preparations. Bench includes a registered patent attorney.
DOJ
FBI
HHS-OIG
IRS
NAMFCU
DEA
McKesson
OptumRx
"I spent nine years prosecuting healthcare cases for the DOJ. Then I ran compliance for the largest healthcare company in America. Now I use what I learned on both sides to defend the people being investigated."
After leaving the U.S. Attorney's Office, I served as Chief Compliance Officer at UnitedHealth Group and Chief Counsel at McKesson - overseeing legal operations for companies generating hundreds of billions in revenue. I founded Health Law Alliance because pharmacies, physicians, and healthcare companies deserve defense counsel who genuinely understand how PBMs build audit cases, how DOJ prosecutors decide what to charge, and how the DEA evaluates registrants. We know - because we used to do it.
Former federal prosecutors and senior executives from UnitedHealth, OptumRx, and McKesson - now defending the providers they used to sit across from.
Get My Free Case ReviewOur bench includes a former prosecutor, a 32-year DEA Diversion Program Manager, and senior healthcare executives who understand enforcement from every side of the table.
A former prosecutor, a former DEA Diversion Program Manager, and senior healthcare-industry executives who know exactly how enforcement agencies build their cases - and how to dismantle them.
Our founding partner served as CCO at UnitedHealth Group and Chief Counsel at McKesson. We understand PBM audit tactics, pharmaceutical supply chain, and industry operations firsthand.
Over 1,500 pharmacy audits overseen, 2,500+ clients represented, and documented wins including declined federal charges, dropped Medicaid prosecutions, and reversed network terminations.
DOJ dismissed its entire case against a NJ physician - the lone dismissal among 35 related prosecutions.
All seven OptumRx terminations reversed in a single coordinated appeal.
$4.7M OptumRx demand reduced to $180K - a 96% reduction on appeal.
Speak with an experienced attorney today at no cost - evaluate your situation and learn how we can help. Confidential, no obligation.